NCT03502330 2024-07-03APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell CarcinomaYale UniversityPhase 1 Completed42 enrolled 17 charts
NCT03158272 2020-12-21A Study of Cabiralzumab Given by Itself or With Nivolumab in Advanced Cancer or Cancer That Has SpreadBristol-Myers SquibbPhase 1 Completed19 enrolled 26 charts